Arcturus Therapeutics (ARCT) is continuing to evaluate the use of LUNAR-CF [ARCT-032] for the treatment of patients with Cystic Fibrosis [CF]. Read our latest report on the stock here.
Half the country seems to be sick with some form of a cold and it feels impossible to escape the epidemic of sniffles, chesty coughs and sneezes both at home and in the office. New analysis by Asthma ...